期刊文献+

壳聚糖纳米粒制备研究进展及在靶向给药系统中的应用 被引量:4

The Research Progress of Preparation of Chitosan Nanoparticles and Its Application in the Targeted Drug Delivery System
下载PDF
导出
摘要 壳聚糖因其独特的物理、化学及生物学特性,已经成为制备纳米制剂的理想材料。用于壳聚糖纳米粒制备的方法很多,用其包载抗肿瘤药物、基因等有着明显的优势,且壳聚糖纳米粒在靶向给药系统中也受到越来越多的关注。本文综述了壳聚糖纳米粒的制备方法及其在靶向给药系统中的应用进展。 Chitosan is an ideal nano-formulation material due to its special physical, chemical and biological properties. Various methods have been established for the preparation of chitosan nanoparticles and obvious advantages of chitosan nanoparticles loading anticancer drugs and genes have been showed. Chitosan nanoparticles used in the targeted drug delivery system has attracted more and more attention. This paper outlined the main preparation methods and the application in the targeted drug delivery system.
出处 《中国执业药师》 CAS 2013年第4期34-38,共5页 China Licensed Pharmacist
基金 厦门市科学技术计划项目(3502Z20114007)
关键词 壳聚糖 纳米粒 制备 靶向给药系统 Chitosan Nanoparticles Preparation Targeted Drug Delivery System
  • 相关文献

参考文献31

  • 1Chae SY,Son S,Lee M,et al. Deoxycholie acid-conjugated chi- tosan oligosaccharide nanoparticles for efficient gene carrier [J]. J Control Release, 2005,109 ( 1-3 ) : 330-344.
  • 2林爱华,刘奕明,平其能.壳聚糖纳米粒表面游离氨基与纳米粒特性研究[J].药学学报,2007,42(3):323-328. 被引量:24
  • 3Sugamori T, Iwase H,Maeda M, et al. Local hemostatic effects of microcrystalline partially deacetylated chitin hydrochloride [J]. J Biomed Mater Res, 2000,49 (2) : 225 -232.
  • 4Howling GI, Detmar PW, Goddard PA, et al. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro[J]. Biomaterials, 2001,22 (22) : 2959-2966.
  • 5Aksungur P,Sungur A,Unal S,et al. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies[J]. J Control Release, 2004,98 (2) : 269-279.
  • 6Ohya Y, Shiratani M, Kobayashi H, et al. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluo- rouracil coated with Polysaccharides and their cell specific cyto- toxicity[J]. Pure and Applied Chemistry, 1994,4 (31 ) : 629-642..
  • 7Kumbar SG,Kulkarni AR,Aminabhavi TM. Cross-linked chi- tosan microspheres for encapsulation of diclofenac sodium: effect of cross-linking agent[J]. J Microencapsu1,2002,19 (2) : 173-180.
  • 8Bodmeier R, Chen HG, Paeratakul O. A novel approach to the o- ral delivery of micro-or nano-particles [J]. Pharmaceutical Re- search, 1989,6(5) :413.
  • 9Zheng AP, Wang JC, Lu WL, et al. Thymopentin-Loaded PH-sen- sitive chitosan nanoparticles for oral administration:preparation, characterization and pharmaco- dynamics[J]. J Nanosci Nanotech-no,2006,6(10):2936-2944.
  • 10Fernandez UR, Cavlo P,Remunan LC, et al. Enhancement of nasal absorption of insulin using chitosan nanoparticles[J]. Phar- maceutical Research, 1999,16(10) : 1576-1581.

二级参考文献40

共引文献57

同被引文献48

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部